How should I immediately treat and plan long‑term management for an adult female with recurrent stress‑triggered anaphylaxis, ongoing angioedema and urticaria, limited epinephrine auto‑injector supply, and a history of psoriasis, psoriatic arthritis, polycystic ovary syndrome, positive antinuclear antibodies, and possible workplace mold exposure?

Immediate Management of Active Anaphylaxis with Ongoing Symptoms

This patient is currently experiencing active anaphylaxis with ongoing angioedema, urticaria, and systemic symptoms—she requires immediate intramuscular epinephrine administration NOW, not just observation. 1

Acute Treatment Protocol

Administer intramuscular epinephrine immediately:

• Dose: 0.3-0.5 mg (0.3-0.5 mL of 1:1000 solution) IM into the anterolateral thigh (vastus lateralis) 1, 2, 3
• This is the ONLY first-line treatment for anaphylaxis—antihistamines like Benadryl are second-line adjuncts and should never be used alone 2, 4
• The patient's current Benadryl-only approach is inadequate and potentially dangerous

After epinephrine administration:

• Position patient supine with legs elevated if hypotension develops 2, 5
• Administer high-flow oxygen if available
• Monitor vital signs closely—repeat epinephrine every 5-10 minutes if symptoms persist or worsen 1
• Consider activating EMS given this is her fifth episode and she has ongoing symptoms despite antihistamine use

Common pitfall: The patient is experiencing active anaphylaxis RIGHT NOW in your clinic with visible lip swelling, hives, and systemic symptoms. This requires immediate epinephrine, not just planning for future episodes.

Emergency Department Consideration

Given the severity markers present, strongly consider immediate ED transfer:

• This is her fifth episode of anaphylaxis
• She has ongoing active symptoms despite antihistamine use
• She required EpiPen use in the most recent episode with respiratory involvement
• Risk factors for biphasic reaction include severe initial presentation and potential need for multiple epinephrine doses 6

Observation period: Patients with severe anaphylaxis requiring epinephrine should be observed for extended periods (typically 4-6 hours minimum, though evidence for optimal duration is limited) to monitor for biphasic reactions, which occur in 7-18% of cases 1, 6

Immediate EpiPen Supply Issue—Critical Priority

This patient has only ONE remaining EpiPen and recurrent anaphylaxis—this is a medical emergency requiring immediate action:

1. Prescribe 2 new EpiPen devices TODAY before she leaves your clinic 4, 7

   • All patients at risk for anaphylaxis should carry TWO autoinjectors at all times
   • One device is insufficient given her recurrent episodes

2. Provide temporary supply if insurance delays:

   • Use manufacturer samples if available
   • Contact EpiPen assistance program immediately (1-800-796-9526)
   • Consider generic epinephrine autoinjectors (significantly less expensive)
   • Some pharmacies can provide emergency supply pending prior authorization

3. Document medical necessity clearly for insurance approval given her documented recurrent anaphylaxis with respiratory involvement

Long-Term Management Strategy

Diagnostic Workup Priority

Your proposed 7-day antihistamine-free period is DANGEROUS and should NOT be done while she has active ongoing symptoms. 5

Immediate testing (can be done while on antihistamines):

• Baseline serum tryptase level NOW (not during acute episode) 8, 5, 7

  • Elevated baseline tryptase (>11.4 ng/mL) suggests underlying mast cell disorder
  • If elevated, calculate β-tryptase to total tryptase ratio
  • Ratio >20 suggests systemic mastocytosis; ≤10 suggests other causes 2, 5

• Hereditary alpha-tryptasemia genetic testing (buccal swab, not bone marrow) 5

  • Associated with MCAS and elevated baseline tryptase
  • Does not require antihistamine washout

Testing requiring antihistamine washout (defer until episodes controlled):

• Alpha-gal IgE testing (can actually be done on antihistamines—this is a blood test) 2, 9
• Comprehensive food allergy panel
• Consider specific IgE testing for common triggers

Mast Cell Activation Syndrome (MCAS) Evaluation

Your clinical suspicion for MCAS is appropriate given:

• Recurrent anaphylaxis without clear trigger
• Stress-triggered episodes
• Multiple organ system involvement
• Autoimmune comorbidities (psoriasis, psoriatic arthritis, positive ANA)

MCAS diagnostic criteria require: 5

1. Episodic symptoms consistent with mast cell mediator release affecting ≥2 organ systems
2. Documentation of elevated mast cell mediator levels during symptomatic period
3. Response to medications targeting mast cell mediators

Critical testing during NEXT acute episode:

• Serum tryptase within 1-2 hours of symptom onset (compare to baseline) 8, 5
• 24-hour urine for N-methylhistamine and/or prostaglandin D2 metabolites (11β-PGF2α)
• Plasma histamine is NOT recommended (too unstable) 5

Chronic Preventive Therapy—Start Immediately

Do NOT wait for testing results to initiate preventive therapy given recurrent severe episodes: 5

1. H1 antihistamine (non-sedating preferred):

   • Cetirizine 10 mg twice daily OR
   • Fexofenadine 180 mg twice daily
   • Can increase to 2-4 times standard dosing if needed 5
   • More effective than Zyrtec once daily she was previously taking

2. Add H2 antihistamine:

   • Famotidine 20 mg twice daily 2, 5
   • Combination H1+H2 superior to H1 alone 2
   • Particularly helpful for GI symptoms

3. Consider oral cromolyn sodium:

   • 200 mg four times daily (before meals and bedtime) 5
   • Particularly effective for GI symptoms and may help neuropsychiatric manifestations
   • Mast cell stabilizer that prevents mediator release

4. Leukotriene antagonist:

   • Montelukast 10 mg daily 5
   • May reduce frequency and severity of episodes

Important consideration: Her psoriatic arthritis treatment should be reviewed—certain biologics may affect anaphylaxis risk, though cardiovascular considerations typically outweigh anaphylaxis risk for most medications 10

Trigger Identification and Avoidance

Stress as trigger: While stress can lower the threshold for anaphylaxis, it is rarely the sole trigger 9

Investigate cofactors that lower threshold:

• Exercise (exercise-induced anaphylaxis or food-dependent exercise-induced anaphylaxis) 2
• NSAIDs/aspirin use
• Alcohol consumption
• Infections or illness
• Menstrual cycle phase
• Temperature extremes

Workplace mold exposure: While mold can cause respiratory symptoms, it does not typically cause IgE-mediated anaphylaxis. However, chronic inflammatory response syndrome (CIRS) evaluation may be reasonable if other causes excluded.

Alpha-gal allergy must be ruled out: 9

• Delayed anaphylaxis (3-6 hours) after red meat consumption
• Patient reports "only water" during last episode—clarify timing relative to last meal
• Can present with stress-triggered appearance if stress occurs during latent period

Specialist Referral—Urgent

Refer to allergist/immunologist within 1-2 weeks (not months): 2, 7

• Recurrent anaphylaxis of unclear etiology
• Possible MCAS requiring specialized evaluation
• Need for comprehensive allergy testing with proper interpretation
• Potential need for advanced therapies if standard preventive measures fail

Consider hematology referral if: 2, 5

• Baseline tryptase >20 ng/mL
• β-tryptase to total tryptase ratio >20
• Bone marrow biopsy may be indicated to evaluate for systemic mastocytosis

Patient Education—Critical Before Discharge Today

Epinephrine autoinjector training:

• Demonstrate proper technique on trainer device
• Inject into anterolateral thigh through clothing if needed 1, 3
• Hold for 3 seconds, massage injection site
• Patient must demonstrate back to you

When to use epinephrine: 4, 7

• ANY respiratory symptoms (throat tightness, wheezing, difficulty breathing)
• Hypotension symptoms (dizziness, syncope, feeling faint)
• Multi-system involvement (skin + respiratory OR skin + GI OR skin + cardiovascular)
• Do NOT wait for symptoms to worsen

After epinephrine use: 11, 7

• If prompt, complete, and durable response within 15 minutes: can consider watchful waiting at home with close monitoring
• Call 911 if: symptoms persist >15 minutes, symptoms worsen, respiratory distress, hypotension, or any concern
• Position supine if feeling faint
• Second dose may be given after 5-10 minutes if inadequate response 1

Avoidance pending workup:

• Avoid known triggers once identified
• Avoid exercise for 4-6 hours after eating (if food-dependent exercise-induced anaphylaxis suspected) 2
• Avoid NSAIDs and alcohol until evaluation complete
• Minimize stress where possible (though not sole trigger)

Medical alert identification:

• Obtain MedicAlert bracelet or similar 2
• Document anaphylaxis history in wallet card

Medication Considerations

Beta-blockers and ACE inhibitors: 7

• Patient does not appear to be on these currently
• If prescribed in future for cardiovascular indications, the risk of stopping these medications typically exceeds the risk of more severe anaphylaxis
• However, may complicate anaphylaxis treatment (glucagon may be needed if on beta-blockers) 2

Psoriasis/psoriatic arthritis treatment:

• Continue current biologic therapy (Zorvye sample given)
• No evidence to suggest stopping would reduce anaphylaxis risk
• Monitor for any temporal relationship between biologic administration and episodes

Follow-Up Timeline

Within 24-48 hours:

• Phone call to ensure adequate EpiPen supply obtained
• Confirm patient understanding of when/how to use epinephrine
• Assess response to increased antihistamine dosing

Within 1-2 weeks:

• Review baseline tryptase results
• Review alpha-gal and other allergy testing results
• Allergist appointment should be scheduled
• Reassess symptom frequency on preventive therapy

Sooner if:

• Any further anaphylaxis episodes
• Worsening symptoms despite preventive therapy
• Unable to obtain EpiPen devices

This patient requires immediate action today—not just planning for future management. Her active symptoms, limited epinephrine supply, and recurrent severe episodes constitute a medical emergency requiring aggressive intervention now.